Global Contraceptives Market Research and Forecast 2018-2023
Contraceptives are referred to drugs and devices that are used to alter or avoid the normal process of fertilization in the body, in order to prevent or reduce the probability of pregnancy. The contraceptive drugs, surgical procedures, and medical devices are used to provide a barrier and inhibit the chances of unintended pregnancy, including sexually transmitted diseases. A range of contraceptives devices and treatments are available for both women and men that can be used to prevent pregnancy. The contraceptives are available in the form of pills, patch, injectables, coil, loop, and T-shaped devices, and are mainly made up of plastics or metals.
Global contraceptives market is expected to grow rapidly due to increasing adoption of contraceptive drugs and devices in the emerging economies such as India and China. Major drivers involved in the growth of the market are rising prevalence of sexually transmitted diseases globally and increasing significance of family planning in the Asia Pacific. At the same time, the substantial increase in the investments in print advertisements and digital advertisements is significantly contributing in the growth of the global contraceptives market. The side effects associated with the contraceptive drugs and devices is the major factor hampering the market growth. Moreover, the growing geriatric population and rising prevalence of infertility among women due to sedentary lifestyle are some other factors that are restraining the growth of the global contraceptives market. However, the increasing demand for affordable contraceptives method, which includes Sino-Implants and introduction of novel contraceptive methods such as SILCs diaphragms is expected to fuel the market growth in the near future.
The contraceptives market can be segmented on the basis of product type, distribution channel, and end users. Based on product type, the market is segmented into contraceptive drugs and contraceptive devices. Contraceptive drugs can be further segmented into oral contraceptives, contraceptive injectables, topical contraceptive patch, and others (contraceptive gels, jellies, and cream). Contraceptives devices can be categorized into male contraceptive devices and female contraceptive devices. Female contraceptive devices can be segmented into female condoms, contraceptive diaphragms, contraceptive sponges, contraceptive vaginal rings, intrauterine devices (IUDs), sub-dermal contraceptive implants, and non-surgical permanent contraceptive devices. Based on the distribution channel, the market is segmented into hospital pharmacy, retail stores, e-commerce, and others (fertility centers). Based on end users, the market is diversified into hospitals, household, clinics, and ambulatory surgical centers. Among the type of products, the contraceptive devices segment holds the largest market share in the global contraceptives market. This is majorly attributed to the wide adoption of male and female condoms across the globe. These contraceptive devices are easy-to-use, inexpensive, and consists of least side effects, which in turn, increases its demand among the youth across the globe.
The global contraceptives market is further analyzed on the basis of the geographical regions that are contributing in the growth of the market. North America contributes the largest market share in the global contraceptives market. This is mainly owing rapid development in the contraceptive methods in the region. Moreover, the supportive government regulations and initiatives taken by the regulatory bodies to increase awareness regarding the sexually transmitted diseases are some other factors that are significantly fueling the market growth. Asia Pacific is projected to be the most opportunistic region in the global contraceptives market over the forecast period. This is due to favorable family planning policies led by the government and introduction of various reimbursement policies such as the AIDS care policy is expected to positively impact the revenue of contraceptives market in the region.
Some of the key players operating in the global contraceptives market are Allergan, Bayer AG, Church & Dwight Co., Inc., Cipla Limited, CooperSurgical Inc., Mankind Pharma, Merck & Co., Inc., Pfizer Limited, Teva Pharmaceuticals, Inc., and The Female Health Company Ltd., among others. In order to sustain in the competitive market, these players adopt various strategies such as acquisitions, mergers, expansions, joint ventures, and product development, among others. For instance, in July, 2018, the Government of India has launched an app “Antararaj” in the states of India. The app will enable user in the tracking of the usage of contraceptive services, which in turn, will minimizes the chances of drop-out.
RESEARCH METHODOLOGY
The market study of contraceptives market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
Secondary sources include:
Financial reports of companies involved in the market
Authentic Public Databases such as United Nations (UN), World Health Organizations (WHO), U.S. Department of Health & Human Services, org, Family Planning Association, and National Women’s Health Resource Center, among others.
Whitepapers, research-papers, and news blogs
Company websites and their product catalogue
Supplier Websites such as Alibaba, amazon for pricing analysis
The report is intended for contraceptive drug and devices manufacturers, healthcare provider, third-party manufacturers, and government organizations for overall market analysis, and competitive analysis. The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers, initial norms and vehicle segment. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.
MARKET SEGMENTATION:
Global contraceptives market is segmented on the basis of regional outlook and following segments:
Global Contraceptives Market Research and Analysis, By Product Type
Global Contraceptives Market Research and Analysis, By Distribution Channel
Global Contraceptives Market Research and Analysis, By End Users
Global Contraceptives Market Research and Analysis, By Region
THE REPORT COVERS:
Comprehensive research methodology of global contraceptives market
This report also includes detailed and extensive market overview with key analyst insights
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations
Analysis of regional regulations and other government policies impacting the global contraceptives market
Insights about market determinants which are stimulating the global contraceptives market
Detailed and extensive market segments with regional distribution of forecasted revenues
Extensive profiles and recent developments of market players
Global contraceptives market is expected to grow rapidly due to increasing adoption of contraceptive drugs and devices in the emerging economies such as India and China. Major drivers involved in the growth of the market are rising prevalence of sexually transmitted diseases globally and increasing significance of family planning in the Asia Pacific. At the same time, the substantial increase in the investments in print advertisements and digital advertisements is significantly contributing in the growth of the global contraceptives market. The side effects associated with the contraceptive drugs and devices is the major factor hampering the market growth. Moreover, the growing geriatric population and rising prevalence of infertility among women due to sedentary lifestyle are some other factors that are restraining the growth of the global contraceptives market. However, the increasing demand for affordable contraceptives method, which includes Sino-Implants and introduction of novel contraceptive methods such as SILCs diaphragms is expected to fuel the market growth in the near future.
The contraceptives market can be segmented on the basis of product type, distribution channel, and end users. Based on product type, the market is segmented into contraceptive drugs and contraceptive devices. Contraceptive drugs can be further segmented into oral contraceptives, contraceptive injectables, topical contraceptive patch, and others (contraceptive gels, jellies, and cream). Contraceptives devices can be categorized into male contraceptive devices and female contraceptive devices. Female contraceptive devices can be segmented into female condoms, contraceptive diaphragms, contraceptive sponges, contraceptive vaginal rings, intrauterine devices (IUDs), sub-dermal contraceptive implants, and non-surgical permanent contraceptive devices. Based on the distribution channel, the market is segmented into hospital pharmacy, retail stores, e-commerce, and others (fertility centers). Based on end users, the market is diversified into hospitals, household, clinics, and ambulatory surgical centers. Among the type of products, the contraceptive devices segment holds the largest market share in the global contraceptives market. This is majorly attributed to the wide adoption of male and female condoms across the globe. These contraceptive devices are easy-to-use, inexpensive, and consists of least side effects, which in turn, increases its demand among the youth across the globe.
The global contraceptives market is further analyzed on the basis of the geographical regions that are contributing in the growth of the market. North America contributes the largest market share in the global contraceptives market. This is mainly owing rapid development in the contraceptive methods in the region. Moreover, the supportive government regulations and initiatives taken by the regulatory bodies to increase awareness regarding the sexually transmitted diseases are some other factors that are significantly fueling the market growth. Asia Pacific is projected to be the most opportunistic region in the global contraceptives market over the forecast period. This is due to favorable family planning policies led by the government and introduction of various reimbursement policies such as the AIDS care policy is expected to positively impact the revenue of contraceptives market in the region.
Some of the key players operating in the global contraceptives market are Allergan, Bayer AG, Church & Dwight Co., Inc., Cipla Limited, CooperSurgical Inc., Mankind Pharma, Merck & Co., Inc., Pfizer Limited, Teva Pharmaceuticals, Inc., and The Female Health Company Ltd., among others. In order to sustain in the competitive market, these players adopt various strategies such as acquisitions, mergers, expansions, joint ventures, and product development, among others. For instance, in July, 2018, the Government of India has launched an app “Antararaj” in the states of India. The app will enable user in the tracking of the usage of contraceptive services, which in turn, will minimizes the chances of drop-out.
RESEARCH METHODOLOGY
The market study of contraceptives market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.
Secondary sources include:
Financial reports of companies involved in the market
Authentic Public Databases such as United Nations (UN), World Health Organizations (WHO), U.S. Department of Health & Human Services, org, Family Planning Association, and National Women’s Health Resource Center, among others.
Whitepapers, research-papers, and news blogs
Company websites and their product catalogue
Supplier Websites such as Alibaba, amazon for pricing analysis
The report is intended for contraceptive drug and devices manufacturers, healthcare provider, third-party manufacturers, and government organizations for overall market analysis, and competitive analysis. The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers, initial norms and vehicle segment. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.
MARKET SEGMENTATION:
Global contraceptives market is segmented on the basis of regional outlook and following segments:
Global Contraceptives Market Research and Analysis, By Product Type
Global Contraceptives Market Research and Analysis, By Distribution Channel
Global Contraceptives Market Research and Analysis, By End Users
Global Contraceptives Market Research and Analysis, By Region
THE REPORT COVERS:
Comprehensive research methodology of global contraceptives market
This report also includes detailed and extensive market overview with key analyst insights
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations
Analysis of regional regulations and other government policies impacting the global contraceptives market
Insights about market determinants which are stimulating the global contraceptives market
Detailed and extensive market segments with regional distribution of forecasted revenues
Extensive profiles and recent developments of market players
CHAPTER 1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHT & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1.1. UNITED STATES
2.3.1.2. EUROPEAN UNION
2.3.1.3. CHINA
2.3.1.4. INDIA
CHAPTER 3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INCREASING ADOPTION OF CONTRACEPTIVES IN EMERGING ECONOMIES
3.1.2. RISING PREVALENCE OF SEXUALLY TRANSMITTED DISEASES
3.1.3. GOVERNMENT INITIATIVES REGARDING EARLY PREVENTION OF UNINTENDED PREGNANCIES
3.1.4. INCREASING SIGNIFICANCE OF FAMILY PLANNING
3.1.5. SUBSTANTIAL INCREASE IN THE INVESTMENTS ON ADVERTISEMENT
3.2. RESTRAINTS
3.2.1. SIDE EFFECTS OF CONTRACEPTIVE DRUGS AND DEVICES
3.2.2. GROWING GERIATRIC POPULATION
3.2.3. RISING PREVALENCE OF INFERTILITY AMONG WOMEN
3.3. OPPORTUNITIES
3.3.1. DOORSTEP DELIVERY OF CONTRACEPTIVES IN RURAL AREAS
3.3.2. INTRODUCTION OF NOVEL METHODS SUCH AS SILCS DIAPHRAGMS
3.3.3. INCREASING DEMAND FOR AFFORDABLE CONTRACEPTIVE DEVICES SUCH AS SINO-IMPLANTS
CHAPTER 4. MARKET SEGMENTATION
4.1. GLOBAL CONTRACEPTIVES MARKET, BY PRODUCT TYPE
4.1.1. CONTRACEPTIVE DRUGS
4.1.1.1. ORAL CONTRACEPTIVES
4.1.1.1.1. PROGESTIN-ONLY CONTRACEPTIVES(MINI-PILLS)
4.1.1.1.2. COMBINED CONTRACEPTIVES
4.1.1.1.2.1. MONOPHASIC PILLS
4.1.1.1.2.2. MULTIPHASIC PILLS
4.1.1.2. CONTRACEPTIVE INJECTABLES
4.1.1.3. TOPICAL CONTRACEPTIVE PATCH
4.1.1.4. OTHERS (CONTRACEPTIVE GELS, JELLIES, AND CREAMS)
4.1.2. CONTRACEPTIVE DEVICES
4.1.2.1. MALE CONTRACEPTIVE DEVICES
4.1.2.1.1. MALE CONDOMS
4.1.2.1.2. MALE CONTRACEPTIVE IMPLANTS
4.1.2.2. FEMALE CONTRACEPTIVE DEVICES
4.1.2.2.1. FEMALE CONDOMS
4.1.2.2.2. CONTRACEPTIVE DIAPHRAGMS
4.1.2.2.3. CONTRACEPTIVE SPONGES
4.1.2.2.4. CONTRACEPTIVE VAGINAL RINGS
4.1.2.2.5. INTRAUTERINE DEVICES (IUDS)
4.1.2.2.5.1. COPPER IUDS
4.1.2.2.5.2. HORMONAL IUDS
4.1.2.2.6. SUB-DERMAL CONTRACEPTIVE IMPLANTS
4.1.2.2.7. NON-SURGICAL PERMANENT CONTRACEPTIVE DEVICES
4.2. GLOBAL CONTRACEPTIVES MARKET, BY DISTRIBUTION CHANNEL
4.2.1. HOSPITAL PHARMACY
4.2.1.1. PUBLIC
4.2.1.2. PRIVATE
4.2.2. RETAIL STORES
4.2.3. E-COMMERCE
4.2.4. OTHERS (FERTILITY CENTERS)
4.3. GLOBAL CONTRACEPTIVES MARKET, BY END USERS
4.3.1. HOSPITALS
4.3.2. HOUSEHOLD
4.3.3. CLINICS
4.3.4. AMBULATORY SURGICAL CENTERS
CHAPTER 5. COMPETITIVE LANDSCAPE
CHAPTER 6. REGIONAL ANALYSIS
6.1. NORTH AMERICAN
6.1.1. UNITED STATES
6.1.2. CANADA
6.2. EUROPE
6.2.1. U.K
6.2.2. GERMANY
6.2.3. ITALY
6.2.4. SPAIN
6.2.5. FRANCE
6.2.6. ROE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. ROAPAC
6.4. REST OF THE WORLD
CHAPTER 7. COMPANY PROFILES
7.1. AABHA CONTRACEPTIVES PVT. LTD.
7.2. AGILE THERAPEUTICS, INC.
7.3. ALKEM HEALTH CARE
7.4. ALLERGAN
7.5. APOTHECUS PHARMACEUTICAL CORP
7.6. BAYER AG
7.7. BLAIREX LABORATORIES, INC.
7.8. CAYA
7.9. CHURCH & DWIGHT CO., INC.
7.10. CIPLA LIMITED
7.11. CONTRALINE, INC.
7.12. COOPERSURGICAL INC.
7.13. CUPID LIMITED
7.14. EGEMEN INTERNATIONAL
7.15. FOUNDATION CONSUMER HEALTHCARE
7.16. GYNEAS
7.17. HLL LIFECARE LIMITED
7.18. JANSSEN-CILAG LIMITED
7.19. LUPIN PHARMACEUTICALS, INC.
7.20. MANKIND PHARMA
7.21. MAYER LABORATORIES, INC.
7.22. MEDICINES360
7.23. MEDISAFE DISTRIBUTION INC.
7.24. MELBEA INNOVATIONS
7.25. MERCK & CO., INC.
7.26. MERIL LIFE SCIENCES PVT. LTD.
7.27. MITHRA PHARMACEUTICALS
7.28. MONA LISA
7.29. MYLAN N.V.
7.30. PFIZER LIMITED
7.31. PIRAMAL ENTERPRISES
7.32. PREGNA INTERNATIONAL LIMITED
7.33. QPHARMA AB
7.34. RECKITT BENCKISER GROUP PLC
7.35. SHANGHAI DAHUA PHARMACEUTICAL CO., LTD.
7.36. SMB CORPORATION OF INDIA
7.37. SYZYGY HEALTHCARE LLC
7.38. TAIWAN FUJI LATEX CO., LTD.
7.39. TEVA PHARMACEUTICALS, INC.
7.40. THE FEMALE HEALTH COMPANY LTD.
7.41. TRIMEDIC INC.
7.42. TTK HEALTHCARE
7.43. VARDHAMAN LIFECARE PVT LTD
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS
CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHT & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1.1. UNITED STATES
2.3.1.2. EUROPEAN UNION
2.3.1.3. CHINA
2.3.1.4. INDIA
CHAPTER 3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INCREASING ADOPTION OF CONTRACEPTIVES IN EMERGING ECONOMIES
3.1.2. RISING PREVALENCE OF SEXUALLY TRANSMITTED DISEASES
3.1.3. GOVERNMENT INITIATIVES REGARDING EARLY PREVENTION OF UNINTENDED PREGNANCIES
3.1.4. INCREASING SIGNIFICANCE OF FAMILY PLANNING
3.1.5. SUBSTANTIAL INCREASE IN THE INVESTMENTS ON ADVERTISEMENT
3.2. RESTRAINTS
3.2.1. SIDE EFFECTS OF CONTRACEPTIVE DRUGS AND DEVICES
3.2.2. GROWING GERIATRIC POPULATION
3.2.3. RISING PREVALENCE OF INFERTILITY AMONG WOMEN
3.3. OPPORTUNITIES
3.3.1. DOORSTEP DELIVERY OF CONTRACEPTIVES IN RURAL AREAS
3.3.2. INTRODUCTION OF NOVEL METHODS SUCH AS SILCS DIAPHRAGMS
3.3.3. INCREASING DEMAND FOR AFFORDABLE CONTRACEPTIVE DEVICES SUCH AS SINO-IMPLANTS
CHAPTER 4. MARKET SEGMENTATION
4.1. GLOBAL CONTRACEPTIVES MARKET, BY PRODUCT TYPE
4.1.1. CONTRACEPTIVE DRUGS
4.1.1.1. ORAL CONTRACEPTIVES
4.1.1.1.1. PROGESTIN-ONLY CONTRACEPTIVES(MINI-PILLS)
4.1.1.1.2. COMBINED CONTRACEPTIVES
4.1.1.1.2.1. MONOPHASIC PILLS
4.1.1.1.2.2. MULTIPHASIC PILLS
4.1.1.2. CONTRACEPTIVE INJECTABLES
4.1.1.3. TOPICAL CONTRACEPTIVE PATCH
4.1.1.4. OTHERS (CONTRACEPTIVE GELS, JELLIES, AND CREAMS)
4.1.2. CONTRACEPTIVE DEVICES
4.1.2.1. MALE CONTRACEPTIVE DEVICES
4.1.2.1.1. MALE CONDOMS
4.1.2.1.2. MALE CONTRACEPTIVE IMPLANTS
4.1.2.2. FEMALE CONTRACEPTIVE DEVICES
4.1.2.2.1. FEMALE CONDOMS
4.1.2.2.2. CONTRACEPTIVE DIAPHRAGMS
4.1.2.2.3. CONTRACEPTIVE SPONGES
4.1.2.2.4. CONTRACEPTIVE VAGINAL RINGS
4.1.2.2.5. INTRAUTERINE DEVICES (IUDS)
4.1.2.2.5.1. COPPER IUDS
4.1.2.2.5.2. HORMONAL IUDS
4.1.2.2.6. SUB-DERMAL CONTRACEPTIVE IMPLANTS
4.1.2.2.7. NON-SURGICAL PERMANENT CONTRACEPTIVE DEVICES
4.2. GLOBAL CONTRACEPTIVES MARKET, BY DISTRIBUTION CHANNEL
4.2.1. HOSPITAL PHARMACY
4.2.1.1. PUBLIC
4.2.1.2. PRIVATE
4.2.2. RETAIL STORES
4.2.3. E-COMMERCE
4.2.4. OTHERS (FERTILITY CENTERS)
4.3. GLOBAL CONTRACEPTIVES MARKET, BY END USERS
4.3.1. HOSPITALS
4.3.2. HOUSEHOLD
4.3.3. CLINICS
4.3.4. AMBULATORY SURGICAL CENTERS
CHAPTER 5. COMPETITIVE LANDSCAPE
CHAPTER 6. REGIONAL ANALYSIS
6.1. NORTH AMERICAN
6.1.1. UNITED STATES
6.1.2. CANADA
6.2. EUROPE
6.2.1. U.K
6.2.2. GERMANY
6.2.3. ITALY
6.2.4. SPAIN
6.2.5. FRANCE
6.2.6. ROE
6.3. ASIA PACIFIC
6.3.1. INDIA
6.3.2. CHINA
6.3.3. JAPAN
6.3.4. ROAPAC
6.4. REST OF THE WORLD
CHAPTER 7. COMPANY PROFILES
7.1. AABHA CONTRACEPTIVES PVT. LTD.
7.2. AGILE THERAPEUTICS, INC.
7.3. ALKEM HEALTH CARE
7.4. ALLERGAN
7.5. APOTHECUS PHARMACEUTICAL CORP
7.6. BAYER AG
7.7. BLAIREX LABORATORIES, INC.
7.8. CAYA
7.9. CHURCH & DWIGHT CO., INC.
7.10. CIPLA LIMITED
7.11. CONTRALINE, INC.
7.12. COOPERSURGICAL INC.
7.13. CUPID LIMITED
7.14. EGEMEN INTERNATIONAL
7.15. FOUNDATION CONSUMER HEALTHCARE
7.16. GYNEAS
7.17. HLL LIFECARE LIMITED
7.18. JANSSEN-CILAG LIMITED
7.19. LUPIN PHARMACEUTICALS, INC.
7.20. MANKIND PHARMA
7.21. MAYER LABORATORIES, INC.
7.22. MEDICINES360
7.23. MEDISAFE DISTRIBUTION INC.
7.24. MELBEA INNOVATIONS
7.25. MERCK & CO., INC.
7.26. MERIL LIFE SCIENCES PVT. LTD.
7.27. MITHRA PHARMACEUTICALS
7.28. MONA LISA
7.29. MYLAN N.V.
7.30. PFIZER LIMITED
7.31. PIRAMAL ENTERPRISES
7.32. PREGNA INTERNATIONAL LIMITED
7.33. QPHARMA AB
7.34. RECKITT BENCKISER GROUP PLC
7.35. SHANGHAI DAHUA PHARMACEUTICAL CO., LTD.
7.36. SMB CORPORATION OF INDIA
7.37. SYZYGY HEALTHCARE LLC
7.38. TAIWAN FUJI LATEX CO., LTD.
7.39. TEVA PHARMACEUTICALS, INC.
7.40. THE FEMALE HEALTH COMPANY LTD.
7.41. TRIMEDIC INC.
7.42. TTK HEALTHCARE
7.43. VARDHAMAN LIFECARE PVT LTD
LIST OF TABLES
TABLE 1 GLOBAL CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2017-2023 ($ MILLION)
TABLE 2 GLOBAL CONTRACEPTIVE DRUGS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 3 GLOBAL ORAL CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 4 GLOBAL PROGESTIN-ONLY CONTRACEPTIVES(MINI-PILLS) MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 5 GLOBAL COMBINED CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 6 GLOBAL MONOPHASIC PILLS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 7 GLOBAL MULTIPHASIC PILLS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 8 GLOBAL CONTRACEPTIVE INJECTABLES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 9 GLOBAL TOPICAL CONTRACEPTIVE PATCH MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 10 GLOBAL OTHERS (CONTRACEPTIVE GELS, JELLIES, AND CREAMS) MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 11 GLOBAL CONTRACEPTIVE DEVICES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 12 GLOBAL MALE CONTRACEPTIVE DEVICES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 13 GLOBAL MALE CONDOMS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 14 GLOBAL MALE CONTRACEPTIVE IMPLANTS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 15 GLOBAL FEMALE CONTRACEPTIVE DEVICES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 16 GLOBAL FEMALE CONDOMS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 17 GLOBAL CONTRACEPTIVE DIAPHRAGMS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 18 GLOBAL CONTRACEPTIVE SPONGES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 19 GLOBAL CONTRACEPTIVE VAGINAL RINGS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 20 GLOBAL INTRAUTERINE DEVICES (IUDS) MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 21 GLOBAL COPPER IUDS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 22 GLOBAL HORMONAL IUDS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 23 GLOBAL SUB-DERMAL CONTRACEPTIVE IMPLANTS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 24 GLOBAL NON-SURGICAL PERMANENT CONTRACEPTIVE DEVICES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 25 GLOBAL CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-2023 ($ MILLION)
TABLE 26 GLOBAL HOSPITAL PHARMACY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 27 GLOBAL PUBLIC MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 28 GLOBAL PRIVATE MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 29 GLOBAL RETAIL STORES END USER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 30 GLOBAL E-COMMERCE MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 31 GLOBAL OTHERS (FERTILITY CENTERS) MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 32 GLOBAL CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY END USERS, 2017-2023 ($ MILLION)
TABLE 33 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 34 GLOBAL HOUSEHOLD MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 35 GLOBAL CLINICS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 36 GLOBAL AMBULATORY SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 37 GLOBAL CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
TABLE 38 NORTH AMERICAN CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE 39 NORTH AMERICAN CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2017-2023 ($ MILLION)
TABLE 40 NORTH AMERICAN CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-2023 ($ MILLION)
TABLE 41 NORTH AMERICAN CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
TABLE 42 EUROPEAN CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE 43 EUROPEAN CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2017-2023 ($ MILLION)
TABLE 44 EUROPEAN CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-2023 ($ MILLION)
TABLE 45 EUROPEAN CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
TABLE 46 APAC CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE 47 APAC CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2017-2023 ($ MILLION)
TABLE 48 APAC CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-2023 ($ MILLION)
TABLE 49 APAC CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
TABLE 50 ROW CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2017-2023 ($ MILLION)
TABLE 51 ROW CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-2023 ($ MILLION)
TABLE 52 ROW CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
TABLE 1 GLOBAL CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2017-2023 ($ MILLION)
TABLE 2 GLOBAL CONTRACEPTIVE DRUGS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 3 GLOBAL ORAL CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 4 GLOBAL PROGESTIN-ONLY CONTRACEPTIVES(MINI-PILLS) MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 5 GLOBAL COMBINED CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 6 GLOBAL MONOPHASIC PILLS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 7 GLOBAL MULTIPHASIC PILLS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 8 GLOBAL CONTRACEPTIVE INJECTABLES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 9 GLOBAL TOPICAL CONTRACEPTIVE PATCH MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 10 GLOBAL OTHERS (CONTRACEPTIVE GELS, JELLIES, AND CREAMS) MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 11 GLOBAL CONTRACEPTIVE DEVICES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 12 GLOBAL MALE CONTRACEPTIVE DEVICES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 13 GLOBAL MALE CONDOMS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 14 GLOBAL MALE CONTRACEPTIVE IMPLANTS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 15 GLOBAL FEMALE CONTRACEPTIVE DEVICES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 16 GLOBAL FEMALE CONDOMS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 17 GLOBAL CONTRACEPTIVE DIAPHRAGMS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 18 GLOBAL CONTRACEPTIVE SPONGES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 19 GLOBAL CONTRACEPTIVE VAGINAL RINGS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 20 GLOBAL INTRAUTERINE DEVICES (IUDS) MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 21 GLOBAL COPPER IUDS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 22 GLOBAL HORMONAL IUDS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 23 GLOBAL SUB-DERMAL CONTRACEPTIVE IMPLANTS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 24 GLOBAL NON-SURGICAL PERMANENT CONTRACEPTIVE DEVICES MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 25 GLOBAL CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-2023 ($ MILLION)
TABLE 26 GLOBAL HOSPITAL PHARMACY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 27 GLOBAL PUBLIC MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 28 GLOBAL PRIVATE MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 29 GLOBAL RETAIL STORES END USER MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 30 GLOBAL E-COMMERCE MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 31 GLOBAL OTHERS (FERTILITY CENTERS) MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 32 GLOBAL CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY END USERS, 2017-2023 ($ MILLION)
TABLE 33 GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 34 GLOBAL HOUSEHOLD MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 35 GLOBAL CLINICS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 36 GLOBAL AMBULATORY SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
TABLE 37 GLOBAL CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
TABLE 38 NORTH AMERICAN CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE 39 NORTH AMERICAN CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2017-2023 ($ MILLION)
TABLE 40 NORTH AMERICAN CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-2023 ($ MILLION)
TABLE 41 NORTH AMERICAN CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
TABLE 42 EUROPEAN CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE 43 EUROPEAN CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2017-2023 ($ MILLION)
TABLE 44 EUROPEAN CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-2023 ($ MILLION)
TABLE 45 EUROPEAN CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
TABLE 46 APAC CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
TABLE 47 APAC CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2017-2023 ($ MILLION)
TABLE 48 APAC CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-2023 ($ MILLION)
TABLE 49 APAC CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
TABLE 50 ROW CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2017-2023 ($ MILLION)
TABLE 51 ROW CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2017-2023 ($ MILLION)
TABLE 52 ROW CONTRACEPTIVES MARKET RESEARCH AND ANALYSIS BY END USER, 2017-2023 ($ MILLION)
LIST OF FIGURES
FIGURE 1 GLOBAL CONTRACEPTIVES MARKET SHARE BY PRODUCT TYPE, 2017 VS 2023 (%)
FIGURE 2 GLOBAL CONTRACEPTIVES MARKET SHARE BY DISTRIBUTION CHANNEL, 2017 VS 2023 (%)
FIGURE 3 GLOBAL CONTRACEPTIVES MARKET SHARE BY END USER, 2017 VS 2023 (%)
FIGURE 4 US CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 5 CANADA CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 6 UK CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 7 FRANCE CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 8 GERMANY CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 9 ITALY CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 10 SPAIN CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 11 ROE CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 12 INDIA CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 13 CHINA CONTRACEPTIVES MARKETSIZE, 2017-2023 ($ MILLION)
FIGURE 14 JAPAN CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 15 ROAPAC CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 16 REST OF THE WORLD CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
COMPANIES MENTIONED
1. AABHA CONTRACEPTIVES PVT. LTD.
2. AGILE THERAPEUTICS, INC.
3. ALKEM HEALTH CARE
4. ALLERGAN
5. APOTHECUS PHARMACEUTICAL CORP
6. BAYER AG
7. BLAIREX LABORATORIES, INC.
8. CAYA
9. CHURCH & DWIGHT CO., INC.
10. CIPLA LIMITED
11. CONTRALINE, INC.
12. COOPERSURGICAL INC.
13. CUPID LIMITED
14. EGEMEN INTERNATIONAL
15. FOUNDATION CONSUMER HEALTHCARE
16. GYNEAS
1 HLL LIFECARE LIMITED
18. JANSSEN-CILAG LIMITED
19. LUPIN PHARMACEUTICALS, INC.
20. MANKIND PHARMA
21. MAYER LABORATORIES, INC.
22. MEDICINES360
23. MEDISAFE DISTRIBUTION INC.
24. MELBEA INNOVATIONS
25. MERCK & CO., INC.
26. MERIL LIFE SCIENCES PVT. LTD.
27. MITHRA PHARMACEUTICALS
28. MONA LISA
29. MYLAN N.V.
30. PFIZER LIMITED
31. PIRAMAL ENTERPRISES
32. PREGNA INTERNATIONAL LIMITED
33. QPHARMA AB
34. RECKITT BENCKISER GROUP PLC
35. SHANGHAI DAHUA PHARMACEUTICAL CO., LTD.
36. SMB CORPORATION OF INDIA
37. SYZYGY HEALTHCARE LLC
38. TAIWAN FUJI LATEX CO., LTD.
39. TEVA PHARMACEUTICALS, INC.
40. THE FEMALE HEALTH COMPANY LTD.
41. TRIMEDIC INC.
42. TTK HEALTHCARE
43. VARDHAMAN LIFECARE PVT LTD
FIGURE 1 GLOBAL CONTRACEPTIVES MARKET SHARE BY PRODUCT TYPE, 2017 VS 2023 (%)
FIGURE 2 GLOBAL CONTRACEPTIVES MARKET SHARE BY DISTRIBUTION CHANNEL, 2017 VS 2023 (%)
FIGURE 3 GLOBAL CONTRACEPTIVES MARKET SHARE BY END USER, 2017 VS 2023 (%)
FIGURE 4 US CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 5 CANADA CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 6 UK CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 7 FRANCE CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 8 GERMANY CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 9 ITALY CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 10 SPAIN CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 11 ROE CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 12 INDIA CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 13 CHINA CONTRACEPTIVES MARKETSIZE, 2017-2023 ($ MILLION)
FIGURE 14 JAPAN CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 15 ROAPAC CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
FIGURE 16 REST OF THE WORLD CONTRACEPTIVES MARKET SIZE, 2017-2023 ($ MILLION)
COMPANIES MENTIONED
1. AABHA CONTRACEPTIVES PVT. LTD.
2. AGILE THERAPEUTICS, INC.
3. ALKEM HEALTH CARE
4. ALLERGAN
5. APOTHECUS PHARMACEUTICAL CORP
6. BAYER AG
7. BLAIREX LABORATORIES, INC.
8. CAYA
9. CHURCH & DWIGHT CO., INC.
10. CIPLA LIMITED
11. CONTRALINE, INC.
12. COOPERSURGICAL INC.
13. CUPID LIMITED
14. EGEMEN INTERNATIONAL
15. FOUNDATION CONSUMER HEALTHCARE
16. GYNEAS
1 HLL LIFECARE LIMITED
18. JANSSEN-CILAG LIMITED
19. LUPIN PHARMACEUTICALS, INC.
20. MANKIND PHARMA
21. MAYER LABORATORIES, INC.
22. MEDICINES360
23. MEDISAFE DISTRIBUTION INC.
24. MELBEA INNOVATIONS
25. MERCK & CO., INC.
26. MERIL LIFE SCIENCES PVT. LTD.
27. MITHRA PHARMACEUTICALS
28. MONA LISA
29. MYLAN N.V.
30. PFIZER LIMITED
31. PIRAMAL ENTERPRISES
32. PREGNA INTERNATIONAL LIMITED
33. QPHARMA AB
34. RECKITT BENCKISER GROUP PLC
35. SHANGHAI DAHUA PHARMACEUTICAL CO., LTD.
36. SMB CORPORATION OF INDIA
37. SYZYGY HEALTHCARE LLC
38. TAIWAN FUJI LATEX CO., LTD.
39. TEVA PHARMACEUTICALS, INC.
40. THE FEMALE HEALTH COMPANY LTD.
41. TRIMEDIC INC.
42. TTK HEALTHCARE
43. VARDHAMAN LIFECARE PVT LTD
